Approval · Notice of Compliance 15247 · 2014
A180: Notice of Compliance 15247
Issued February 13, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15247
- Date
- February 13, 2014
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification hnumber (din) holder
- Therapeutic class
- Antibacterial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| A180 | 02261200 | Marketed |
Medicinal ingredients
- DANOFLOXACIN MESYLATE 180 MG per ML